Heidenreich, Axel and Pfister, David (2018). Even 'low-dose' cabazitaxel requires careful and meticulous patient selection. BJU Int., 121 (2). S. 163 - 165. HOBOKEN: WILEY. ISSN 1464-410X

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Heidenreich, AxelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pfister, DavidUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-197982
DOI: 10.1111/bju.13879
Journal or Publication Title: BJU Int.
Volume: 121
Number: 2
Page Range: S. 163 - 165
Date: 2018
Publisher: WILEY
Place of Publication: HOBOKEN
ISSN: 1464-410X
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
COMPASSIONATE-USE PROGRAM; PROSTATE-CANCER; MANAGEMENTMultiple languages
Urology & NephrologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/19798

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item